Elan Corporation, PLC - Tysabri US Reintroduction FDA Approval Call - Research and Markets offers a transcript of 'Elan Corporation, PLC' Conference Call.DUBLIN, Ireland -- The Elan Corporation, PLC (NYSE NYSE See: New York Stock Exchange :ELN Noun 1. ELN - a Marxist terrorist group formed in 1963 by Colombian intellectuals who were inspired by the Cuban Revolution; responsible for a campaign of mass kidnappings and resistance to the government's efforts to stop the drug trade; "ELN kidnappers target ) Corporate Conference Call took place on 6-Jun-06 8:30am ET. The Co. reported on 06/06/06 that the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. has decided to allow TYSABRI back in the market and make it available to patients. BIIB BIIB Basic Imagery Interpretation Brief believes that the reintroduction of TYSABRI offers new hope as an important therapeutic choice for patients living with a disabling and devastating disease. More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/90285. This document provides verbatim text of the conference call. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion